Intracoronary or intravenous abciximab after aspiration thrombectomy in patients with STEMI undergoing primary percutaneous coronary intervention.

CONCLUSIONS: IC versus IV abciximab did not enhance myocardial reperfusion in non-selected patients with STEMI undergoing primary PCI after aspiration thrombectomy had successfully been performed.
PMID: 30460974 [PubMed - as supplied by publisher]

Source: Cardiovascular Journal of Africa - November 20, 2018 Category: Cardiology Authors: Bedjaoui A, Allal K, Lounes MS, Belhadi CE, Mekarnia A, Sediki S, Kara M, Azaza A, Monsuez JJ, Benkhedda S Tags: Cardiovasc J Afr Source Type: research